VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $131,890 | -55.7% | 30,530 | -1.2% | 0.00% | -75.0% |
Q3 2020 | $298,000 | +22.6% | 30,900 | +108.8% | 0.00% | +100.0% |
Q4 2019 | $243,000 | -46.4% | 14,800 | -56.6% | 0.00% | -33.3% |
Q3 2019 | $453,000 | +19.2% | 34,100 | +26.5% | 0.00% | -25.0% |
Q2 2019 | $380,000 | -75.0% | 26,955 | -59.2% | 0.00% | -73.3% |
Q3 2018 | $1,518,000 | -53.6% | 66,111 | -65.9% | 0.02% | -42.3% |
Q1 2018 | $3,270,000 | – | 194,070 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |